Cuba has a lung cancer vaccine
Izvršni rezime - terapijska vakcina CIMAvax EGF
Protokol faze III kliničkog ispitivanja vakcine CIMAvax EGF
Medicc review
Periodični izveštaj o sigurnosti CIMAvax EGF
Shema imunizacije sa CIMAvax EGF-om

Predavanja sa IV Internacionalnog kongresa o vakcini CIMAvax EGF
održan u Havani, 22. i 23. novembra 2011. godine.

Algoritmo diagnostico terapeutico e inclusion en Cancer de pulmon en Villa Clara

CANCER IMMUNOTHERAPY AND THE EMERGING PARADIMGS IN CLINCAL RESEARCH

CIMAvax EGF in advanced stages NSCLC patients unfit for chemotherapy

CIMAvax EGF treatment concomitant with first-line chemotherapy in NSCLC patients ( stage IIIA non-surgical)

EXPERIENCIA CLINICA PERUANA CON CIMAVAX EGF

History of therapy in advanced NSCLC

Immunemonitoring challenges in cancer immunotherapy

Manufacturing Biopharmaceuticals for Immunotherapy Challenges and Opportunities

Phase II III VChV Schedule Immune Response Analysis

Phase III ChVV Schedule Immune Response Analysis

Phase III Clinical Trial Phase II Clinical Trial Vaccine-Chemotherapy-Vaccine

PHASE III EVALUATION OF SURVIVAL OF PATIENT WITH

Aneks X Izveštaja o sigurnosti Faza IV Septembar 2011